These independent CME/CE activities are supported by educational grants from Genentech

Pfizer
The Advanced Certificate Program in
Lung Cancer Management II
  1. Curriculum III
  2. Curriculum II
  3. Curriculum I
  4. Full Course List

Currently Available

Course Title Curriculum Faculty Release Date
Expert Insight Into: Induction Chemotherapy Followed By Concurrent Chemotherapy And Dose-Escalated Thoracic Conformal Radiotherapy In Stage III NSCLC—Article Review (LC02.17) 1871.12 II Gore Aug 2009
Case Study: NSCLC (Squamous Cell Carcinoma) in a Patient with COPD—Tx Reporter with Audio (LC02.16) 1872.04 II Herbst
Gore
Unger		 Aug 2009
Expert Insight Into: Postoperative Radiation Therapy in Patients with Complete Resection and Stage I, II, or IIIA NSCLC Treated with Adjuvant Chemotherapy—Article Review (LC02.15) 1871.11 II Gore Jul 2009
Management of Stage III, N2 NSCLC: A Virtual Thoracic Oncology Tumor Board—Webcast (LC02.14) 1873 II Herbst
Langer
Gore
Shrager
Unger		 Jun 2009
Expert Insight Into: Randomized Phase II Trial of Erlotinib or Standard Chemotherapy in Patients with Advanced Non–Small-Cell Lung Cancer and a Performance Status of 2—Article Review (LC02.13) 1871.09 II Langer May 2009
Case Study: Small-Cell Lung Cancer—Tx Reporter e-Newsletter (LC02.12) 1872.03 II Herbst
Gore		 Apr 2009
Expert Insight Into: Thoracoscopic Lobectomy Facilitates the Delivery of Chemotherapy After Resection for Lung Cancer—Article Review (LC02.11) 1871.08 II Shrager Apr 2009
Expert Insight Into: Consolidation Therapy (Docetaxel) Stage III NSCLC—Article Review (LC02.10) 1871.07 II Langer Apr 2009
Expert Insight Into: Irinotecan Plus Carboplatin Versus Oral Etoposide Plus Carboplatin In Extensive Small-Cell Lung Cancer: A Randomized Phase III Trial —Article Review (LC02.09) 1871.10 II Govindan Mar 2009
Case Study: Limited Multifocal Bronchioloalveolar Adenocarcinoma (BAC)—Tx Reporter e-Newsletter (LC02.08) 1872.02 II Herbst
Shrager		 Mar 2009
Expert Insight Into: Minimally Invasive Endoscopic Staging of Suspected Lung Cancer—Article Review (LC02.07) 1871.05 II Unger Feb 2009
Expert Insight Into: Increased EGFR Gene Copy Number Detected by Fluorescent In Situ Hybridization (FISH) Predicts Outcome in Non–Small-Cell Lung Cancer Patients Treated with Cetuximab and Chemotherapy—Article Review (LC02.06) 1871.06 II Herbst Jan 2009
Case Study: Management of Advanced NSCLC—Tx Reporter e-Newsletter (LC02.05) 1872.01 II Herbst
Langer
Govindan		 Jan 2009
Expert Insight Into: Sublobar Resection for Patients with Peripheral Small Adenocarcinomas of the Lung: Surgical Outcome is Associated with Features on Computed Tomographic Imaging—Article Review (LC02.04) 1871.04 II Shrager Dec 2008
Expert Insight Into: The IASLC Lung Cancer Staging Project: Proposals for the Revision of the T Descriptors in the Forthcoming (Seventh) Edition of the TNM Classification for Lung Cancer —Article Review (LC02.03) 1871.03 II Shrager Nov 2008
Expert Insight Into: Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer—Article Review (LC02.02) 1871.02 II Langer Oct 2008
Expert Insight Into: New Guidelines in the Treatment of Non–Small-Cell Lung Cancer (NSCLC)—Article Review (LC02.01) 1871.01 II Herbst Oct 2008